COVID-19 vaccine is in human trial phase

Research groups across the globe are targetting a potential vaccine that will prove to be a powerful shield against COVID-19. The scientists at the Kaiser Permanente Washington Research Institute in Seattle began an anxiously awaited first-stage study of a potential COVID-19 vaccine developed in record time after the new virus that erupted from China.